Effect of immunotherapy on oncological and patientst reported outcomes in patients with urothelial cancer

Effect of immunotherapy on oncological and patientst reported outcomes in patients with urothelial cancer - Effect of immunotherapy on oncological and patientst reported outcomes in patients with urothelial cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038747

Enrollment

200

Registered

2019-12-01

Start date

2019-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urothelial carcinoma

Interventions

Treatment group: Patients received immunotherapy for UC Control group: Standard chemotherapy: Patients received either gemcitabine 800 mg/m2 on days 1, 8, and 15 plus cisplatin 70 mg/m2 (GCis) on d

60 mL/min/1.73m2) or presence of frailty.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Urothelial cancer who need systemic therapy or immunotherapy

Exclusion criteria

Exclusion criteria: History of severe cardiac conditions, such as angina requiring certain treatment with nitrates, unstable angina defined for study, positive cardiac stress test before starting the study. History of significant central nervous system (CNS) injuries (including stroke or spinal cord injury) within 6 months of Visit 1. History of drug, alcohol, or substance abuse within the 6 months before Visit 1. Have any condition, limitation, or disease that could, in the judgment of the investigator, preclude evaluation of response to therapy and QoL

Design outcomes

Primary

Measure	Time frame
Effects of immunotherapy on oncological outcomes inpatients with urothelial cancer	—

Secondary

Measure	Time frame
Effects of immunotherapy on patient reported outcomes inpatients with urothelial cancer	—

Countries

Japan

Contacts

Public ContactShingo Hatakeyama

Hirosaki Univ. Urology

shingoh@hirosaki-u.ac.jp0172-39-5091

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026